Bioconjugation of interferon-alpha molecules to lysine-capped gold nanoparticles for further drug delivery applications

Gold nanoparticles are potentially very attractive components for therapeutic delivery since they can be synthesized with any diameter from 1 to 200nm to carry a payload of therapeutic molecules into a cell without triggering an immune response. Gold nanoparticles must undergo surface transformations before coupling to therapeutic molecules to become eligible for this purpose. It is now more understood that amine groups can bind to gold nanoparticles strongly, which has enabled surface modification of gold nanoparticles with amino acid lysine through its amine group. These lysine capped gold nanoparticles can further be coupled to therapeutic molecules for delivery purposes. In this study gold nanoparticles were first synthesized and capped with lysine molecules. TEM and FTIR measurements demonstrated the synthesis of lysine-capped gold nanoparticles with an average diameter of 10 nanometers. Interferon alpha molecules-one of the most important therapeutic protein were then chemically bound to lysine-capped gold nanoparticles through a two-step process of diimide-activated amidation. The conjugation of interferon molecules to lysine capped gold nanoparticles was carried out via the reaction between the free amine group of lysine and carboxyl groups of interferon using N-ethyl-N'-13-dimethyl-aminopropyl (EDAC) as a coupling agent. The process of conjugation has also been studied by transmission electron microscopy.